Kebilidi, AADC deficiency gene therapy, now approved by FDA
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The FDA has approved a gene therapy called Kebilidi for the treatment of AADC deficiency. Kebilidi is a brain-delivered gene therapy, and its approval marks a first for this type of treatment. The therapy has been used to successfully treat AADC deficiency, although details of its use and cost are not specified.
Full coverage
1
News-Medical·Aug 192
CGTLive®·Nov 133
Fierce Pharma·Nov 144
pharmaphorum·Nov 145
RegMedNet·Nov 146
MedCity News·Nov 147
BioSpace·Nov 148Fierce Pharma·Aug 11